Focused on precision oncology and rare genetic diseases, this biotech reported a significant insider sale amid strong ...
In the expanding field of peptide-based research, a combination of two bioactive molecules—BPC‑157 and TB‑500—has garnered ...
Courtney is a registered nurse with over 13 years of experience in the clinical setting, helping individuals navigate their way through their healthcare journeys. She has been in the frontlines ...
Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce ...
This important study identifies PRRT2 as an auxiliary regulator of Nav channel slow inactivation, proposing that PRRT2 facilitates entry into, and delays recovery from, the slow-inactivated state. The ...
MedPage Today on MSN
FcRn Blockers Vie to Become First Approved Drug for Sjogren's Disease
FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...
Up-to-date computational pipeline characterizes G-protein-coupled receptor (GPCR) repertoires in the closest relatives of metazoans, providing a framework to investigate the evolutionary origins and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback